Skip to content

A Human Experimental Model for Neuropathic Pain Using Combined Application of Capsaicin and Local Anesthetics

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01540877
Enrollment
28
Registered
2012-02-29
Start date
2011-04-30
Completion date
Unknown
Last updated
2012-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ipsi- and Contralateral Hypoesthesia

Brief summary

Main of the present study was to develop a model of concomitant C-fibre block and sensitization eliciting spontaneous pain as well applying topical capsaicin and local anesthetics (LA) to examine the sensory alterations after combined C-fiber block and sensitization in both different application orders (sensitization of blocked C-fibers and block of sensitized C-fibers), compared to each of both mechanisms alone. Thereby, we expect stronger sensory changes during the combined substance application than during the monoapplication. We expect also contralateral sensory alterations mirroring the changes on the intervention site after the combined capsaicin and LA application, being stronger than after sensitization alone absent after C-fiber block alone.

Interventions

PROCEDUREApplication of capsaicin 0.6%

topical application of 0.6% capsaicin on the volar forearm

PROCEDUREApplication of local anesthetics (EMLA plaster)

topical application of EMLA on the volar forearm

PROCEDUREApplication of 1 capsaicin 0.6% and 2. EMLA

topical application of 1. 0.6% capsaicin and 2. EMLA on the volar forearm

PROCEDUREApplication of 1. EMLA and 2. capsaicin 0.6%

topical application of 1. EMLA and 2. 0.6% capsaicin on the volar forearm

Sponsors

Ruhr University of Bochum
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy subject, older than 18 years, provided written informed consent

Exclusion criteria

* insufficient comprehension of the German language, history of severe internal, neurological or dermatological diseases, substance abuse, manifest psychiatric diseases, chronic and acute pain, any medication intake (except contraceptives in females) regularly or on demand during the last 14 days before study inclusion and during the study period, hypersensitivity to lidocaine or other amide-type anesthetics, hereditary or acquired methemoglobinemia, pregnancy, nursing, abnormal sensory profile in the quantitative sensory testing (QST) with side-to-side differences beyond the normal range at baseline and participation in clinical trials during the last month.

Design outcomes

Primary

MeasureTime frame
grade of the ipsi- and contralateral hypoesthesia6 months

Secondary

MeasureTime frame
area of the ipsi- and contralateral hypoesthesia6 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026